It looks like the US is heading for some serious action on addressing the safe development and use of nanotechnology-enabled materials, products and processes in 2011.  Reading through the just-released National Nanotechnology Initiative’s (NNI) Supplement to the President’s 2011 budget [PDF, 1.2 MB], there are some noteworthy inclusions:

• The US Food and Drug Administration (FDA) is requesting $15 million in 2011 to address nanotechnology environment, safety and health issues.  This is the first time that the agency has been listed in the NNI budget supplement as requesting nanotechnology-specific funding.  Previously hobbled in its approach to supporting the responsible development of nanotechnology because of a lack of funding, this should go a long way to help the agency get on top of critical oversight-related questions.  The requested funds will support laboratory and product testing capacity, scientific staff development and training, and collaborative and interdisciplinary research to address product characterization and safety.
• The US Consumer Products Safety Commission (CPSC) also joins the FDA in being part of the NNI budget cross-cut for the first time since the NNI was formed.  For 2011, the CPSC is requesting a much-needed $2.2 million to allow it to participate with other agencies in researching safety aspects of nanomaterials use in consumer products.  Planned work includes developing protocols to assess the potential release of airborne nanoparticles from various consumer products and to determine their contributions to human exposure; determining whether nanomaterials can be used for performance improvement in sports safety equipment such as helmets and kneepads without creating other health hazards; and expanding consumer product testing using scientifically credible protocols to evaluate the exposure potential from nanosilver in consumer products, with special emphasis on exposures to young children.
• The National Institute for Occupational Safety and Health (NIOSH) is requesting $16.5 million for nanotechnology safety research in 2011; over 5 times more than the agency’s 2006 nanotech budget, and $7 million above the estimated 2010 budget.  NIOSH has been leading the charge on developing safe workplace practices for handling engineered nanomaterials in recent years – and all on a shoestring budget.  This significant increase in funding should help the agency address critical research needs it been struggling to cover adequately, including much needed work on exposure measurement and characterization.
• The National Institute for Standards and Technology (NIST) budget for nanotechnology safety research is set to double, going from an estimated $3.6 million in 2010 to a requested $7.3 million in 2011.  The agency will target its nanotechnology safety program to measuring the dynamic physico-chemical and toxicological properties of key nanomaterials and the release of these nanomaterials during manufacturing processes and from products throughout full product life cycles.

When requests from other agencies are included, the 2011 budget request for targeted nanotechnology safety research across the federal government for 2011 comes to $116.9 million – three times the amount invested in 2006.

This is an extremely welcome move, and demonstrates that the US government is committed to investing in research that will underpin the development of responsible nanotechnology.

Back in 2006, I estimated that the US government needed to invest at least $106 million per year in research addressing short term nanotechnology safety issues.  More recently in 2008, I set out funding options for addressing critical nanotechnology safety needs – arguing that between $20 million and $100 million per year should be invested over and above existing funding at the time (around $60 million per year).  While I can’t take credit for the apparent convergence between recommendations and budget requests here, it is gratifying to see agency-wide investment come closer to what has been suggested is needed in order to make headway in underpinning responsible nanotechnology.

Interestingly, budget requests for five key agencies align reasonably closely with those 2008 recommendations.

EPA, NIH (specifically, the National Institute for Environmental Health Sciences) and NIOSH requests are not too far from what I estimated as a compromise research investment option that lay somewhere between the minimum and the ideal.  What is particularly encouraging though is the requests for NIST and FDA, which far exceed these estimated budgets.

Of course, these requests only tell half the story.  The other half concerns how the funds are spent, and whether they will enable significant progress to be made towards developing responsible uses of nanotechnology.  In the past, the NNI has been criticized for not having a robust nanotechnology safety research strategy and for being weak on supporting targeted safety research within mission-driven agencies.  While the jury is still out on the strategy, there is no doubt that the 2011 marks a significant shift towards supporting safety research within mission-driven agencies.  In 2006, 21% of the nanotechnology environment, safety and health federal research budget was associated with EPA, NIOSH and NIST. for instance  In 2011, that figure is projected to rise to 37%.

We’re not out of the woods yet on ensuring we have the information needed to develop and use new nanotechnology-based materials and products safely.  But it looks like the US is making progress.  And that’s good news for anyone hoping to see the emergence of strong nanotechnology-based solutions to a whole host of challenges.

The unthinkable has happened!  The National Institute for Occupational Safety and Health (NIOSH) is poised to get $5 million in crisp new dollars for researching possible workplace risks arising from nanotechnology.  It may not sound like a big deal.  But believe me—it is…

Back in 2005, NIOSH spent $3 million on nanotechnology risk research—scraped together from various internal sources.  It wasn’t a lot, but it allowed the agency to begin chipping away at a growing problem—how to work safely with the increasingly unusual materials coming out of nanotechnology.  Since then, NIOSH has been doing an annual loaves and fish trick—pushing meager internal funds further than they had any right to go in the pursuit of safer workplaces.

But even with inspired leadership and a smart bunch of researchers, $3 million a year was never enough to cover all of the research needed to underpin safe nanotech workplaces.  Back in 2005, we didn’t know how to measure exposure to nanomaterials, how toxic the new materials being produced were, how to prevent exposure, or how to work with and dispose of the materials safely.  Despite some excellent research, we are still a long way from answering these questions—which makes things tough for the producers, users and regulators of nanotechnology-related products.

Of course, the burden for filling in the knowledge gaps doesn’t lie solely on NIOSH’s shoulders.  Other federal agencies are filling in some of the unknowns under the auspices of the US National Nanotechnology Initiative (NNI).  And collaborations with research partners around the world are helping leverage the limited funds that are available.

Nevertheless, NIOSH is the lead US agency when it comes to underpinning safe workplaces through sound research.  And so far it hasn’t had the resources necessary to do the job when it comes to nanotechnology.

Over the past five years, annual funding for nanotechnology risk research has increased within the agency—it was up to $7 million last year.  But this has always been achieved through redirecting internal funds.  Despite the US Government investing around $1.5 billion per year on nanotechnology research, not a drop of new money has gone NIOSH’s way.

Until now.  Maybe it’s the new administration.  Maybe people are eventually waking up to the fact that successful nanotechnology depends on safe workplaces.  Either way, NIOSH is scheduled to receive $5 million in new funding for nanotechnology risk research next year—bringing the total nanotech research budget to $12 million.

Of course, it isn’t enough to do everything that is necessary.  Even my lowest estimates suggest that the agency need an additional $10 million per year to make significant inroads into the research backlog here.

But it is a major step in the right direction.

That’s not the only good news though.  Browsing through the NNI’s Supplement to the President’s Budget for 2010 [PDF, 3.4MB], a number of agencies will be increasing spending on nanotechnology risk research next year.  Most significantly, the National Institute of Standards and Testing (NIST) will be investing an additional $3 million, and the National Institutes of Health (NIH) an additional $7 million.  Overall, the projected budget for nanotechnology risk research for 2010 is $88 million—$16 million up on this year.

This is great news.  But I do need to add a caveat.  The NNI figures have always tended to encompass research that is relevant to addressing safety concerns, but isn’t necessarily directly focused on the type of research that is needed (this discrepancy was highlighted most recently in a National Academies of Science report).  And so there is a chance that not every dollar in that $88 million will go directly to ensuring the safer use of nanotechnology-related products.

Nevertheless, I am cautiously optimistic that a larger proportion of the funding will be directly relevant to understanding and minimizing risks in 2010.   Funding increases for NIOSH, NIH, NIST and the US Environmental Protection Agency will all directly contribute to a better understanding of potential risks.  And a large chunk of National Science Foundation funding in this area is already tied up in two research centers specifically focused on environmental impacts.

There is still a long way to go if US government-supported research is to get us to where we need to be with developing safe nanotechnologies.  In addition to funding, there is still a need for increased stakeholder involvement in mapping out research directions and a stronger research strategy.

But it seems that under the new administration things are at least moving in the right direction.

And while an additional $5 million for NIOSH may seem a drop in the ocean in the grand scheme of things, it is a major step forward to protecting one of the more vulnerable groups when it comes to engineered nanomaterials—the people making and using the stuff.

Ten years ago to the month, one of the first research reports detailing the challenges of ensuring the safe use of engineered nanomaterials was delivered to the UK Health and Safety Executive.  The report wasn’t for general release, and you’ll be hard pressed to find a copy of it in the public domain.  But as a co-author, I have a copy skulking around in my archives.  And given it’s ten year anniversary, I’ve been browsing through it, to find out how much has progressed—or not, as the case may be!

The report focused on ultrafine aerosols, and the Health and Safety Laboratory’s ability to respond to then-current, and future, research needs.  As such it was pretty wide ranging, and focused extensively on exposure to incidental nanoscale aerosols—such as welding fume and engine emissions—in the workplace.  But it did encompass the then-nascent field of nanotechnology and “nanophase material synthesis.”  And some of these early assessments of the field bear revisiting.

For anyone interested in what was being written about the potential health and safety issues raised by engineered nanomaterials ten years ago, I’ve extracted a few sections of the report below—for the full thing, you’ll have to go to the UK Health and Safety Executive.

My apologies that the post is so long—I’m only expecting a dedicated few to plough through it.  But at the least, you might want to skip to the end to see how the research recommendations of 1999 compare to those of today—you might be surprised!

A scoping study into ultrafine aerosol research and HSL’s ability to respond to current and future research needs.
IR/A/99/03

Kenny, Maynard et al. 1999

The introduction to the report starts:

Over the past few years a number of epidemiological studies have indicated a tentative link between ambient particulate concentrations, and morbidity and mortality rates (e.g. Dochery et al. 1993, Pope 1996, Schwartz et al. 1993, Schwartz et al. 1991).  In all studies, particles with an aerodynamic diameter less than 10 µm (the PM10 fraction) have been implicated as the key agents.  The lack of an apparent association between particles of specific composition and health effects has indicated the observed effects to be due to some physical aspect of the inhaled particles.  A further link between particle size and health has been indicated by Dochery et al. (1993) who showed a more positive correlation between ill health and particles smaller than 2.5 µm than was seen than with the PM10 fraction.  The possibility of correlations between particle size and number concentration and toxicity has been demonstrated by Oberdörster et al. (1995) by exposing rats to PTFE particles ~20 nm in diameter.  At concentrations of 106 particles cm-3 (corresponding to an equivalent mass concentration of approximately 60 µg m-3) rats exposed for 30 minutes died within 4 hours. At lower concentrations a steep dose response curve was observed between pulmonary inflammatory responses and particle number.  More recent research has begun to indicate a possible material-independent link between inhaled particle surface area and selected toxicological endpoints (e.g. Lison et al. 1997). The possibility of a relationship between fine inhaled particles and ill health is now readily accepted,  although research is still at a very early stage and most published data to date are open to a wide range of interpretations.  Tentative hypotheses concerning possible mechanisms leading to toxicity have been proposed (e.g. Schlesinger 1995, Seyton et al. 1995, Donaldson and McNee 1998), and the impact of inhaling ultrafine particles on both the respiratory and cardiovascular systems have been speculated on.  The US EPA have already acted, partially as a response to earlier epidemiological studies, and introduced the PM2.5 sampling standard for environmental particulates.  Whether the UK is to follow this lead is still under discussion.  However, despite these steps, research so far has raised more questions than answers.  There is debate over the interpretation of the epidemiological studies, and the appropriateness of chosen endpoints in toxicology tests.  Contradictory experimental results are beginning to be published regarding ultrafine particle impact on health (e.g. Pekkanen et al. 1997).  There also appear to be widely conflicting views on what constitutes an ultrafine particle, with implicit cut-off points ranging from 10 µm down to a few nm!

In amongst all the current confusion is the question of whether the alleged health implications of inhaling ultrafine aerosols are of relevance to the workplace.  Much has been made of the apparent health problems amongst vulnerable sectors of the general population following environmental exposures, and the argument is followed through to the conclusion that within a healthy workforce similar problems are unlikely to be seen (backed up by a lack of evidence of severe health problems that are clearly linked to ultrafine aerosols).  However, in part the current uncertainty over the toxicity of ultrafine particles is due to the very limited information available on the nature of so-called ultrafine particles.  Inhaled particles associated with health in epidemiology studies have been very poorly defined, and even the particles used in most well controlled in vitro and in vivo experiments have been poorly characterised.  Without basic information on particle size, morphology, composition and structure, it is clearly not feasible to make value judgements on the nature of inhaled particles, either in the general environment or in the workplace. In the light of the scarcity of information on particle characteristics, the Committee on the Medical Aspects of Air Pollutants has recommended the monitoring of such parameters at a number of environmental locations (COMEAP 1996).  Similar measurements will be essential within the workplace before further speculations on the importance of ultrafine aerosols are made.

In reading this, it is important to remember that the state of the science is ten years on from when this was written—there are now a wealth of publications on the potentially health-relevant behavior of nanometer-scale particles.  Yet the framework of questions set out largely remains as relevant now as it did then.

Perhaps more interestingly, in 1999 the discussion was focused on understanding and managing the health impacts of inhaled particles, NOT whether those particles could be classified as arising from nanotechnology or not.  As a result, the document tends to be more grounded in the science of how fine particles potentially impact on health, rather than how the poorly defined field of “nanotechnology” might lead to health effects.

The report goes on to consider the generation of ultrafine aerosols in the workplace:

In general, very little is known about any aspect of ultrafine aerosols in the workplace.  There are a number of processes such as welding and soldering where intuitively one would expect large numbers of sub-µm particles.  However even in these areas, detailed measurements of particle size do not appear to have been made.  There is a general feeling that in situations where large concentrations of particles are generated, agglomeration will remove ultrafine particles from the aerosol before it is inhaled, thus removing the need to consider ultrafines. However this has not been verified, and evidence exists for significant mass concentrations of ultrafines existing close to generation sources.  Interestingly, researchers are currently speculating that agglomerates with ultrafine primary particles may have the equivalent impact on the lungs as the individual primary particles.  More is known about the products of internal combustion engines, although mainly from the view point of monitoring and reducing environmental emissions.  However very little information on the nature of individual particles in the workplace exists.

Ultrafine aerosols tend to be formed either through nucleation (in particular homogeneous nucleation), gas to particle reactions or through the evaporation of liquid droplets.  The majority of workplace ultrafine particles are likely to arise from the nucleation route, either as combustion products, or within saturated vapours arising from other sources (e.g. welding, smelting, laser ablation).  Evaporation of sub-micron and even micron sized droplets of relatively high purity solvents will result in very small particles.  Where the initial particles are highly charged, there is the possibility of any resulting fine particles exceeding the Rayleigh charge limit and fragmenting into even finer particles.  This is a recognised method of generating ultrafine particles through electrospraying.  To what extent this generation route is present in the workplace is unknown, although it is used for the specific generation of ultrafine particles during nanofabrication.  Gas to particle generation of ultrafine aerosols accounts for the majority of non-combustion particles in the environment, although again the significance of this route within the workplace is unclear.

Following current interest in nanophase technology, and the use of ultrafine particles as precursors in nanophase materials, it is likely that the next few years will see an increase in the industrial generation and use of ultrafine particles.  At present the planned generation of particles tends to be isolated to the production of ultrafine metal oxides such as TiO2, ZnO and fumed silica.  Ultrafine carbon black is also currently generated on a commercial scale. Although the full extent to which ultrafine aerosols are generated as an unwanted by-product within industry is still largely unknown, there are clear cases where the generation rate is high, such as in welding and from internal combustion engines.  Even so, data on the nature of generated aerosols in these areas are sparse.

There follows an assessment of different sources of nanoscale particles in the workplace, from welding to plastic fumes from laser cutting, and a range of other sources.  This is all interesting information, but here I want to focus on the section on ultrafine aerosol precursors in nanophase technology:

Over the last ten years, interest in the unique properties associated with materials having structures on a nanometer scale has been increasing at something approaching an exponential rate.  By restricting ordered atomic arrangements to increasingly small volumes, materials begin to be dominated by the atoms and molecules at the surfaces of these ‘domains’, often leading to properties that are startlingly different from the bulk material.  As the domains become smaller, and hence more dominated by surface atoms and surface energies, so the properties become increasingly unique from either the bulk material or the constituent atoms. So for instance, a relatively inert metal or metal oxide may become a highly effective catalyst when manufactured as ultrafine particles; opaque materials may become transparent when composed of nanoparticles, or vice versa; conductors may become insulators, and insulators conductors; nanophase materials may have many times the strength of the bulk material.  All of these effects and many more have been observed with various materials.  Such material properties that are unique to nanostructured materials that have excited both the scientific and industrial communities in recent years.

Most nanophase materials are fabricated either from the liquid state, or the aerosol state, although some routes combine the two.  The liquid route perhaps gives more control over the process in some cases.  However there is a general feeling at the present that using aerosols is an inexpensive and versatile route to constructing these materials.  Although there are many different production methods being explored, the general approach is to generate, capture and process an aerosol of particles with the dimensions of the final nanostructure.  Typically this requires the generation of particles from 1 to 2 nm in diameter up to around 20 – 30 nm in diameter, depending on the required properties of the final material.  Generation rates in research laboratories tend to be low (of the order of mg/hour), although where industrial production of nanoparticles has commenced, production rates of the order of tonnes per hour are seen.

At present, nanophase materials are an emerging technology, with the emphasis most definitely still on the research lab.  However, there is considerable commercial commitment to the field, and it is certain that as scale-up problems are overcome, the mass production of both nanoparticles and nanophase materials will increase rapidly world-wide.  When this occurs, the unique health problems associated with a unique product that can neither be treated as a bulk material or on a molecular level will have to be fully addressed.  In the meantime, there is a clear need to keep up to date with both developments in the technology, and any health concerns that may be associated with it.

Over the past ten years, commercial-scale production of nanoscale materials has moved on significantly, although perhaps not as much as some would have predicted.  Yet the issues surrounding their safety still reflect (by on large) the issues raised here.

The report summarizes the state of nanotechnology research in 1999—which I’ll skip over—and goes on to consider where the rather quaintly termed nanophase technology was heading:

The indication from the scientific press is that there are as many potential applications for nanophase technology as there are groups working in the field.  However a relatively small number of areas can be identified where commercial production of materials is most likely to be seen in the next 5 – 10 years.  To understand the commercial pressure behind the progress of nanophase technology and its likely integration into industry, you only have to consider the potential market for successful applications.  In the electronics industry in particular, the revenue arising from nanotechnology is likely to be well in excess of hundreds of billions of dollars.  In other areas, such as coatings and catalysts, similar markets exist for successful applications.  The market for ‘intelligent’ drug delivery systems, if successful, is likely to be immense.  Reflecting this, the pharmaceutical industry is currently investing in excess of $14B per annum into advanced delivery systems.

Electronic applications

The reduction in particle size has a profound effect on electronic structure as nanometre dimensions are reached, leading to a number of unique electronic properties seen in individual and groups of nanoparticles.  As an illustration, Si, which is semiconducting in the bulk solid, may be used to form nanometre sized pseudo-crystals with one of two types of atomic structure dominating its faces.  Particles with one structure are fully conducting. Those with the other are good insulators. What does this mean/what are the general implications?

Perhaps the most widely recognised electronic property of nanoparticles is their ability to act as quantum dots.  In arrays of such particles, the overall electronic characteristics are dominated by quantum effects within the particles, leading to novel applications.  For instance, quantum dot devices can be used to create high efficiency LED’s and electroluminescent plastics.  High frequency solid state lasers based on quantum dot technology are expected to form the basis of a major breakthrough in telecommunications, leading to significantly higher communication bandwidths.  High speed and high capacity computer memory will also be possible using quantum dot technology.  Success in fabricating viable quantum dot devices will bring about a major technological step within the electronics industry, leading to a $B production industry, although progress at present is limited by the need to fabricate very precise arrays of well characterised particles.  Current approaches include the use of colloids, nanolithography and aerosols.

Porous nanostructured semiconductors such as silicon have recently been shown to have electroluminescent properties.  If this can be fabricated into integrated circuits, the basis for the next generation of high speed optoelectronic computers will be laid.  Nanoparticles are also being found to lead to improved properties in resistors and capacitors.  Ultrafine conducting particles embedded in an insulating matrix have been shown to give a great range of resistances as well as showing very high temperature stability.  Similarly, the use of nanoparticles in capacitors has been shown to give a high dielectric permitivity and a low dissipation factor, making them ideal for high speed computer memory.

A particularly interesting phenomenon seen in nanophase materials is that of electrochromism; the modification of optical properties by the application of an electric field. Windows or mirrors coated with thin layers of these materials show variable light transmittance or reflection based on the magnitude of an applied electric field.  It has also been found that nanophase materials may be used to form thin transparent films with high conductivity.

A number of other important areas relating to electronics are increasingly relying on the use of nanostructured materials.  Solid state gas sensors show improved sensitivity when using films of sintered nanometre particles; high temperature superconductors have a higher performance when formed of nanostructured materials; thermocouples benefit from nanostructure and the magnetic properties of some nanostructured materials is already exploited to the full in magnetic storage media.

Coatings

Using nanophase materials to coat a wide range of substrates is being explored, and has been exploited in a wide range of applications.  Hard nanophase coatings are important in the construction industry.  The use of coatings with specific optical properties is of interest within the glass and photographic film industries.  Dry coating technology is also benefiting from nanophase materials.  It has been shown that the transport properties of large particles may be radically altered by the addition of a thin coating of fine particles of a suitable material.  For instance, coating starch grains with fumed silica results in a highly flowable powder.  In many cases, this coating need only be of the order of nanometres thick, and the use of nanoparticles in dry coating processes is already under investigation.

Chemical-mechanical polishing using nanoparticle slurries.

Surface polishing is a critical step in the processing of silicon wafers prior to semiconductor chip fabrication.  Surface blemishes are a major source of both wafer and chip rejection in the electronics industry.  By using polishing slurries consisting of nanoparticles, planarisation of wafer surfaces with fewer blemishes is possible.

Drug delivery systems.

A key goal in current drug delivery system research is the development of ‘intelligent’ systems that will deliver doses to specific sites within the body.  One approach being actively considered is the use of coated nanoparticles.  These would be capable of penetrating capillaries and being transported directly to the target site.  The coating would include the drug to be delivered, components to prevent an immune response from the body and components to achieve site-specific or condition-specific delivery.

Nanoparticle catalysts

The modified surface chemistry of nanoparticles is well recognised for its catalytic properties in many materials.  This, together with the associated surface area to mass ratio for such particles, has led to intense interest in nanostructured catalysis within many fields.

After laying out the state of the science regarding the potential risks of inhaling nanoscale particles (which has advanced considerably over the past ten years), the report summarises (on the health impacts):

There has been little work in this field to date, so it is difficult to draw meaningful general conclusions from the published data. One of the reasons for this lack of data appears to be the difficulty in generating particles of standard and known size for use in in vitro studies. Particles used in both in vitro and in vivo studies have also tended to be relatively poorly characterised. Different effects both in vitro and in vivo have been observed with different sources of ultrafine particles, so the responses measured may be a function of the particle constituents rather than the particles per se. The differences observed have been attributed to the ability of particles with a particular composition to have different levels of free radical activity at their surface. Whilst there has been some work investigating synergy between acid aerosols and ultrafine particles (see below), there has been no work investigating the synergy between ultrafine particles and other potential airborne contaminants, e.g. allergens, VOC’s and bacteria. Some of the animal models used to demonstrate toxicological endpoints require exposure regimes which are far in excess of any possible exposure in humans (e.g.  6 hours a day, 5 days a week for 3 months). Therefore, the extrapolation of such health effect data to humans should be treated with some caution.
…
Interest in possible health effects following inhalation of ultrafine particles is high at present, and research is beginning to follow this interest.  Inhalation toxicology has taken over from epidemiology over the past few years, and dominates the field at present.  Dose response relationships in rodents are being seen that indicate particle number or surface area to be more appropriate metrics than mass.  The possibility of ultrafine particles acting as vectors to transport  acids and metals to the alveolar region of the lung is also being explored.  However it is recognised that many of the current approaches being taken are lacking in various aspects, particularly regarding the significance of chosen endpoints and the characterisation of particle exposure, and a number of groups are now beginning to address these issues.  This is an area that is particularly ripe for good research proposals to sympathetic funding bodies. The need to fully characterise the particles used in exposure and inhalation tests, as well as those that people are exposed to in the workplace and environment, is well understood, although the right combination of technical skills to achieve this seems to be lacking in many establishments.  In particular there would appear to be significant scope for transferring analytical electron microscopy skills used in materials science and nanostructure analysis to the analysis of ultrafine aerosol particles.  There is also a recognised need for in-vitro test systems that allow cell cultures to be exposed to the aerosol, rather than a particulate suspension.  A small number of research groups are currently developing test systems allowing direct aerosol deposition.  Funding for fine particle research (PM2.5 sampling, and mass-based aerosol sampling) still dominates, but all aspects of ultrafine particle research are on the increase, and it is likely that the next few years will see significant funding opportunities and research in this area.  Driven by concerns over environmental exposure, together with the need to address exposure limits for nuisance dusts, there is increasing interest in examining the impact of ultrafine particle exposure in the workplace.

The report covers a lot of ground on exposure measurement and control, which I won’t duplicate here (although a lot of the information remains highly pertinent).  Instead, I’ll jump right to the end of the report, where a number of research recommendations are made.  Remembering that these are focused specifically on inhalation exposure in the workplace, they sound surprisingly contemporary, being written 10 years ago:

Full quantification of ultrafine aerosol exposure in the workplace:

• Measurement of number, size, surface area, composition, morphology, structure
• Investigation of the surface properties of workplace particles.
• Investigation of surface enrichment, role of modified surface activity below 10 nm, relevance of internal structure.
• Development of instrumentation and analytical techniques for surface area
• measurement and individual particle characterisation (Analytical Electron Microscopy)

Targeted epidemiology and toxicology studies.

• Epidemiological evidence for ultrafine particle toxicity in the workplace
• Toxicity of well defined particles, and of particles characteristic of those found in the workplace.
• Investigation of mechanisms resulting in toxic responses, in relation to the known physical and chemical attributes of workplace particles.

Instrumentation

• Identification of deficiencies in instrumentation and monitoring requirements, and development of new technologies and methods.

Control

• Reassessment of  the applicability of conventional control systems (including RPE) to reduce exposure to ultrafine particles, and the development of new approaches to exposure control.

Exposure Limits

• Assessment of current exposure limits in the light of available data on ultrafine particle toxicity, and the development of more appropriate approaches to exposure limits.

Ten years on, it is surprising how relevant this document still is.  The major issues facing the safe use of nanomaterials were reasonably clear ten years back.  And many of the research needs raised then remain today.  Progress certainly has been made since then, and an understanding of the types of nanomaterials of greater concern has increased—the 1999 report doesn’t mention carbon nanotubes for instance.  But on the flip side, this is a report that was clearly unencumbered by the politics of nanotechnology that seem to have diffused through things today

Perhaps most surprisingly though, is that governments and others are still talking about the same issues – often as if they have discovered them for the first time – without doing that much about them.  It would be churlish to ask where we might have been now if some of those 1999 recommendations were listened to.  But at least I can ask where we might be in 2019, if only we can break out of this endless cycle of re-inventing the nanotech risk report!

Endnote

Because this was an internal report, I have been careful to extract only parts of it that are of general interest and are not in any sense proprietary.  That said, there is a lot of information in the full report that would be helpful to anyone grappling with addressing and managing potential occupational risks arising from nanoscale particle exposure in the workplace.  It would be great if the UK Health and Safety Executive could release it for public use!

References

COMEAP (1996).  Non-biological particles and health.   HMSO Publications.

Dochery, D. W., Pope, C. A., Xu, X., Spengler, J. D., Ware, J. H., Fay, M. E., Ferris, B. G. and Speizer, F. E. (1993).  An association between air pollution and mortality in six U.S. cities.  N. Engl. J. Med, 329, 24, 1753-1759.

Donaldson, K. and McNee, W. (1998).  The mechanics of lung injury caused by PM10.  In: Air Pollution and Pealth.  Eds:  Hester and Harrison.  Royal Society of Chemistry.  ISBN 0-85404-245-8.  pp21-32.

Lison, D., Lardot, C., Huaux, F., Zanetti, G. and Fubini, B. (1997).  Influence of particle surface area on the toxicity of insoluble manganese dioxide dusts. Arch. Toxicol. 71, 725-729

Oberdörster, G., Gelein, R. M., Ferin, J. and Weiss, B. (1995).  Association of particulate air pollution and acute mortality:  involvement of ultrafine particles?  Inhal. Toxicol., 7, 111-124.

Pekkanen J, Timonen KL, Ruuskanen J, Reponen A, Mirme A (1997) Effects of ultrafine and fine particles in urban air on peak expiratory flow among children with asthmatic symptoms. Environ Res 74: 24-33

Pope, C. A. (1996).  Adverse health effects of air pollutants in a nonsmoking population.  Toxicology, 111, 149-155.

Schlesinger, R. B. (1995).  Toxicological evidence for health effects from inhaled particulate pollution:  does it support the human experience?  Inhal. Toxicol., 7, 99-109.

Schwartz, J., Spix, C., Wichmann, H. E. and Malin, E. (1991).  Air pollution and acute respiratory illnessin five German communities.  Environ. Res., 56, 1-4.

Schwartz, J., Slater, D., Larson, T. V., Pierson, W. E. and Koenig, J. Q. (1993).  Particulate air pollution and hospital emergency room visits for asthma in Seattle.  Am. Rev. Respir. Dis., 147, 826-831.

Seyton, A., MacNee, W., Donaldson, K. and Godden, D. (1995).  Particulate air pollution and acute health effects.  The Lancet, 345, 176-178.

The National Research Council of the National Academies releases its review of the National Nanotechnology Initiative Strategy for Nanotechnology-Related Environmental, Health, and Safety Research.  And it’s not pretty.

Most people acknowledge that innovation is vital to economic and social prosperity.  But what do you do when science and technology innovation are in danger of being stymied by bad habits and misguided thinking?  One solution: apply a little tough love.  Something a new report from the US National Academies does in spades.

By the end of the next US administration, there will be an estimated seven billion people on the planet, all wanting food, shelter, and water, and most of them striving for a first-world quality of life.  With dwindling natural resources and an environment struggling to absorb humanity’s assaults, old technologies are coming to the end of their shelf life.   Energy security, curing cancer, quality of life in old age, plentiful clean water, climate change—none of these challenges will be met without science and technology innovation.

More to the point, without a constant stream of science and technology innovation, the economy will be starved of the knowledge-capital so desperately needed for stability and growth.

Given this backdrop, you would think that the US federal government would be on top of spotting and navigating around potential barriers to innovation.  Yet according to a new report from the National Research Council of the National Academies, the feds seem to have their collective heads in the sand when it comes to ensuring investment in science and technology research delivers sustainable results…

The new report specifically addresses nanotechnology.  And it focuses on federal government plans to address potential risks associated with this emerging technology.  But the cracks in the system it reveals are most likely endemic across all areas of science and technology innovation.

Nanotechnology is at the forefront of a handful of emerging technologies that are poised to underpin science and technology innovation over the coming decade.  By gaining increasing control over matter at the scale of atoms and molecules, scientists are opening the doors to technology innovations undreamed of a few years back—computers that run on light; drugs that seek out and destroy cancer cells; batteries that out-perform fossil-fuel alternatives; intelligent packaging that lets you know when food is contaminated.  And these are just the tip of the iceberg.  Lux Research estimates that within five years, over $3 trillion worth of goods sold globally will owe part of their value to nanotechnology.  And while different analysts come up with different projections, it’s hard to escape the potential of nanotechnology to make a significant difference on the world stage.

Yet if this potential is to be realized, innovative science will need to be transformed into innovative technology.  And here’s the rub: if the new technology isn’t safe, isn’t perceived to be safe, or is plagued by uncertainty over how to use it safely, it will be stymied.  And the economic and societal benefits will dwindle from a flood to a trickle.

Already some early nanotechnology-based developments are plagued by uncertainty over potential risks.  Carbon nanotubes for instance—a tremendously exciting new material with applications from super-strong materials to next-generation electronics—have a passing resemblance to asbestos fibers in some configurations.  And a lack of clear information on how to use them safely is dogging a nascent nanotube industry.

Unfortunately the federal government is still struggling to provide the necessary health and safety research and oversight to underpin effective nanotechnology innovation.  The just-released National Academies report reviews the federal strategy for nanotechnology-related environmental, health and safety research. And the conclusion:  There is no strategy!

This is bad news for science and technology innovation, bad news for the economy, and bad news for anyone concerned with climate change, disease treatment, and a whole host of other issues.  Because if we cannot work out the rules of safe use for this new technology, what hope have we of using it to our advantage?

The fifteen person-strong National Academies panel, of which I was a member, unanimously recommended a National Strategy be developed for nanotechnology risk research, that will allow stakeholders to pool their collective wisdom in coming up with a plan for ensuring the long-term success of nanotechnology-based innovation.

But this is only part of the solution to making sure nanotechnology and other emerging technologies succeed.  To turn things around and get science and technology innovation back on track, some tough love is needed.  And that means facing some home truths, and getting rid of some bad habits.

Top of the list of bad habits is a tendency to treat risk-focused studies as economy-class research.  Research into understanding and mitigating potential risks arising from emerging technologies is key to success in innovation. And the more innovative the technologies being developed, the more innovative the risk-research needed to use them wisely.

Then there is a fear of commitment (aka accountability and responsibility).  Even though nanotechnology risk-research dollars are pitifully small compared to overall investment in nanotech R&D, there is a reticence to ensure even these meager dollars are used wisely and responsibly.

Of course, getting federal agencies to work together is tougher than herding cats.  But by developing effective collaborations and partnerships between agencies and with non-government stakeholders, institutional barriers that inhibit effective science and technology innovation can be overcome.

However, such partnerships will depend on a master-plan—which is where a national research strategy is needed.

Third in the catalogue of bad habits is fiscal tight-fistedness.  In the US, the federal government will be stretched to underpin successful nanotechnology innovation without investing between $50 million – $100 million more per year in nanotechnology risk research.  This needs to be targeted toward agencies that can use it to generate useful information.

Some ideas on how this might be done in the short term have just been posted on the web by the Project on Emerging Nanotechnologies.  But in the long term, a National Research Strategy is needed to guide future R&D investment and direction.

I don’t think it is an overstatement to say that nanotechnology and other emerging technologies are vital to the future economic and social well-being of the United States and other countries.  Yet without an ability to spot potential barriers to their development and find innovative solutions to overcome them, we’re never going to get there.

And, quite frankly, the previous US administration blew it—the National Academies report reveals a naïve and blinkered perspective on establishing a research agenda that supports science and technology innovation.

However, it’s time to draw a line under the past mis-steps, and make a fresh start. With President-Elect Obama’s emphasis in science and technology in the US, there is a chance to move on from the muddle of the past and take clear steps towards enabling emerging technologies that that do more good than harm, and that stimulate the economy while helping to address national and global challenges.

Tough love is never comfortable.  But it usually leads to change for the better.  And in the case of nanotechnology, getting health and safety research right will mean that everyone benefits in the end.

In 2004, the US National Nanotechnology Initiative (NNI) had a strategy – and it was OK.  But what has happened since then?  Has progress been made against planned actions?  What have been the major challenges to progress?  Have effective solutions been found?  And how have the lessons and experiences of the last three years influenced strategic nano-thinking in the government?

You might be forgiven for supposing that the updated Strategic Plan – published this week – holds the answers.  No such luck!

This is a document that discusses generalities and avoids specifics.  Whereas the 2004 report laid out a clear action plan for making progress, this report revels in bureaucratic obfuscation.

Cutting through the fog, the updated strategy document emphasizes innovation and business interests – while hinting that societal issues are a necessary inconvenience to progress.  Citizen engagement is recognized as being important, but ideas on how to do it extend little further than public observers at scientific strategy-setting workshops, and maintaining the NNI website.  And while environmental, safety and health issues receive more emphasis than in 2004, there is little sense of a strategy for supporting successful and beneficial nanotechnologies through understanding and managing risks effectively.

Not all is disappointing in this new document though:

• The updated NNI vision for nanotechnology inspires confidence: “a future in which the ability to understand and control matter at the nanoscale leads to a revolution in technology and industry that benefits society.”
• Environment, health and safety research is now recognized as a major subject area in its own right.
• Ten “high impact application opportunities” do a good job of mapping out near-term opportunities—four of which directly deal with the implications of nanotechnology, and two of which align with the grand challenges for safe nanotechnology published in Nature, back in 2006.
• Some of the ideas for making progress have real value – such as exchanging scientists across federal agencies.

Yet at the end of the day, this is a lightweight document, that does not give a concrete assessment of where we are now, and is short on actions we need to take to ensure the development of safe, sustainable and successful nanotechnologies.

And while the plan is grounded in the first phases of nanotechnology development, it lacks the vision of an innovative and transformative nanotechnology future as articulated by Mike Roco and others.  Where is the strategy for fostering and exploiting third and fourth generation nanotechnologies, and synergistic convergences between nanotech, biotech and other “techs?”

Since 2001, the U.S. government has invested nearly $7 billion in nanotechnology R&D.  As the 21st Century Research & Development Act comes up for reauthorization in 2008, Congress is going to be asking: “was it worth it?”  Based on this document, some might be excused for having their doubts.

And yet, the potential for nanotechnology to change the world is clearly there.  As other nations develop their own strategic plans to move up the nanotech ladder, I suspect many in the U.S. will be hoping that this latest exercise in bureaucracy from the NNI is merely the tip of a largely hidden iceberg, rather than a true reflection of reality.

_________________________________________

This post first appeared on the SAFENANO blog in January 2008